INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Former HanesBrands Investors Who Received Gildan (NYSE: GIL) Shares in Connection with Gildan's Acquisition of HanesBrands in December 2025 to Contact the Firm

This is less a cash-flow story than a governance and multiple story. For GIL, the direct dollar cost of a securities claim is usually not the issue; the real penalty is that it keeps a post-merger stock overhang alive and raises the market’s required discount rate for any future acquisition-driven growth. That can shave valuation before it touches earnings, especially if management needs to spend time and reserve capital on defense instead of integration.

The second-order effect is on M&A appetite in consumer/apparel. If plaintiffs’ counsel can attach claims to stock-for-stock deals, boards become more conservative about issuing equity for acquisitions, which can quietly reduce the strategic optionality that supports sector consolidation premiums. Any name with an active roll-up angle or a recent stock-funded deal should trade with a slightly higher litigation discount until the complaint is clarified.

The base case is still nuisance-value economics: these investigations often settle within insurance coverage and do not move EBITDA. The real risk is a broadened complaint that uncovers disclosure weakness around synergy assumptions, integration costs, or fairness-process optics; that would matter because it could hit credibility on future guidance more than the legal bill itself. Near term, the stock reaction is likely driven by headline velocity; over 1-3 months, the key catalyst is whether this stays as a generic investigation or becomes a filed class action with specific damages theories.